department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Cerezyme · pharmadog

pharmadog
drugs
Cerezyme

patient view

This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.

← back to professional view

drug

imiglucerase

Marketedupdated 2mo ago

by Genzyme Corp

Approved

community read0 votes

all catalysts(69)

approval · 69

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

view all 69 catalysts →

News(0)

no news has mentioned this drug yet

brand

Cerezyme

generic

imiglucerase

indication

Gaucher Disease Type III

phase

marketed

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

CEREZYME (IMIGLUCERASE) — FDA approval

Data sources

openFDA · ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 2

drugCEREZYME276 co-mentions · 69 sources
tagApproval276 co-mentions · 69 sources

Trials studying imiglucerase

phase2Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extensionactive not recruitingn=12
N/ABlood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Diseasecompletedn=4
phase3Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3completedn=57
phase3Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3active not recruitingn=43
phase4Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲcompletedn=12